Effects of Extracorporeal Treatment in Patients With Acute Poisoning

NCT06798129 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5269

Last updated 2025-12-05

No results posted yet for this study

Summary

This study aims to estimate the effect of extracorporeal treatments (ECTRs) on 28-day survival in patients with acute poisoning. The treatment strategy was receipt of ECTR (hemoperfusion, hemodialysis, continuous kidney replacement therapy, and/or or plasma exchange) versus a non-ECTR strategy.

Conditions

  • Poisoning
  • Extracorporeal Treatment

Interventions

PROCEDURE

Extracorporeal Treatment

Extracorporeal treatments include hemoperfusion, hemodialysis, continuous kidney replacement therapy, and plasma exchange.

Sponsors & Collaborators

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    lead OTHER

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2023-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06798129 on ClinicalTrials.gov